Tag results:
induced pluripotent stem cells
Cell Therapy News
Japan Team Proves iPS-Based Cornea Transplant Safe in World-1st Trial
[Kyodo News] A Japanese university research team has concluded that the world's first clinical trial, spanning over years, transplanting corneal tissues derived from induced pluripotent stem cells, or iPS cells, into four almost-blind patients was safe and effective.
ESC & iPSC News
Pituitary Lineage Differentiation from Human-Induced Pluripotent Stem Cells in 2D and 3D Cultures
[Stem Cells and Development] Researchers developed a pituitary-like organoid consisting only of gonadotrophs. Despite the lack of success in differentiating gonadotrophs, pituitary-like organoids were differentiated from human-induced pluripotent stem cells.
ESC & iPSC News
Generation of Integration Free hiPSCs Clones, NSi001-A, NSi001-B, and NSi001-C from Peripheral Blood Mononuclear Cells of an Individual with Down Syndrome Having Robertsonian Translocation
[Stem Cell Research] Human hiPSC clones NSi001-A, NSi001-B, and NSi001-C were generated from a female individual of Indian origin having Robertsonian translocation down syndrome by reprogramming peripheral blood mononuclear cells using integration-free Sendai viral vectors.
ESC & iPSC News
Exome Sequencing of Individuals with Huntington’s Disease Implicates FAN1 Nuclease Activity in Slowing CAG Expansion and Disease Onset
[Nature Neuroscience] Mutating endogenous FAN1 to a nuclease-inactive form in an induced pluripotent stem cell model of Huntington’s diseas led to rates of CAG expansion similar to those observed with complete FAN1 knockout.
ESC & iPSC News
Reprogramming and Redifferentiation of Mucosal-Associated Invariant T Cells Reveal Tumor Inhibitory Activity
[eLife] The authors used induced PSC technology to investigate whether murine mucosal-associated invariant T (MAIT) cells functioned as tumor-promoting or inhibitory cells. MAIT cells were reprogrammed into iPSCs and redifferentiated towards MAIT-like cells.
ESC & iPSC News
Generation of Two Human Induced Pluripotent Stem Cell Lines from Fibroblasts of Parkinson’s Disease Patients Carrying the ILE368ASN Mutation in PINK1 (LCSBi002) and the...
[Stem Cell Research] Scientists generated human induced pluripotent stem cells from fibroblasts of a 64-year-old male patient with a homozygous ILE368ASN mutation in PINK1, who experienced disease onset at 33 years.